In recent years, the U.S. government has strengthened its national preparedness and response capabilities for catastrophic disease events, including bioterrorism. But a new study coordinated by the Center for Arms Control and Non-Proliferation, with support from the Carnegie Corporation of New York, reports that the U.S. has paid inadequate attention to prevention and response measures internationally. Read thereport or executive summary.
As a result of this inattention, the study suggests that the country’s vulnerability to a significant biological event has increased. Other countries have become increasingly skeptical about the U.S. commitment to either improving global public health or reducing deliberate and accidental biological risks to global security.
Carnegie Corporation’s work on the nonproliferation of biological weapons has focused on the acute need for facilitating collaboration between security experts and members of the scientific community. By integrating scientists and policymakers, the foundation has helped to inform biological weapons policy while creating opportunities for international dialogue on global biosecurity.
In early 2009, Carnegie Corporation support for this work has entered its closing phase. While the threat of biological weapons has not gone away, today its nature is better understood. And, due to the considerable efforts of the foundation’s grantees, critical steps have been taken to improve communication and strengthen the commitment of key stakeholders to work toward nonproliferation.
- Press Releases
